[Clinical experiences with the new psychoactivator Deanxit (Melitracen and Flupenthixol)].
D000328:Adult; D000873:Anthracenes / Q000627:therapeutic use*; D000928:Antidepressive Agents; D003863:Depression / Q000188:drug therapy; D000431:Ethanol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011293:Premenstrual Syndrome / Q000188:drug therapy; D011437:Propylamines / Q000627:therapeutic use; D011600:Psychopharmacology; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D014149:Tranquilizing Agents; D014966:Xanthenes / Q000627:therapeutic use*
D000873:Anthracenes; D000928:Antidepressive Agents; D010879:Piperazines; D011437:Propylamines; D014149:Tranquilizing Agents; D014966:Xanthenes; D000431:Ethanol
Klinische Erfahrungen mit dem neuen Psychoaktivator Deanxit (Melitracen und Flupenthixol)